Further, the increased sensitivity to estradiol with the addition of Ets1 in tumor growth response, cellular responses, and transcriptional activation suggests that the complexes formed will continue to allow nuclear hormone receptor binding of ligand to stimulate NCOA binding through the AF2 domain of ERα. Here, ERAL1 is linked to neoplasm.